Choi So Rae, Lee Sang Cheol, Kim Beom Seok, Yoon Soo Young, Park Hyeong Cheon, Kang Shin Wook, Choi Kyu Hun, Kim Yu Seun, Ha Seung Kyu, Park Ki Il, Han Dae Suk, Lee Ho Yung
Department of Internal Medicine, Division of Nephrology, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea.
Yonsei Med J. 2003 Jun 30;44(3):454-62. doi: 10.3349/ymj.2003.44.3.454.
The number of diabetic ESRD patients has increased and death rates of diabetic patients on hemodialysis (HD), peritoneal dialysis (PD) and renal transplantation (RT) have remained higher than the death rate of non-diabetic patients. An attempt was made to compare the clinical characteristics, patients' cumulative survival, and technical survival among the three groups retrospectively according to the mode of renal replacement therapy(RRT), and to analyze the risk factors associated with mortality. A total of 229 diabetic ESRD patients diagnosed between 1986 and 1995 at the Severance Hospital who began dialysis or who underwent a kidney transplant were included and their medical charts were reviewed. Hypertension was the most common co-morbid disease in all study groups. The prevalence of cardiovascular disease was the only co-morbid condition that was significantly different among the three groups, which was highest in the PD group (24.4%) and lowest in the RT group (8%). In the analysis of a patient's cumulative survival rate not adjusted for age and sex, the RT group had the highest survival rate, and the cumulative survival rate of the HD and PD group were similar. The 5-year survival rate of the patients treated with HD, PD and RT was 28.8%, 19.8%, and 72.0%, respectively. No differences were observed in the patient's cumulative survival rate between the HD and PD patients even when it was adjusted for age. When adjusted for age, sex and risk factors, the relative death rate of the RT group was significantly lower in male patients younger than 60 years of age. With the exception of male patients younger than 60 years of age, the PD group showed a slightly lower relative death rate although it was not significant. The multiple Cox regression analysis of patient survival showed that age, serum albumin, BUN, mean hospital days, the presence of cardiovascular disease at the initiation of RRT were associated with mortality. The analysis of the technique survival rate revealed a better result in the HD group compared to PD group, but a limitation in being able to investigate the AVF function disturbed the accuracy of the analysis of technical survival rate. In conclusion, the survival rate between the PD and HD patients was not different and the RT group had the best survival rate. Therefore, kidney transplantation in diabetic ESRD patients should be considered positively if no other contraindicated condition for RT exit.
糖尿病终末期肾病(ESRD)患者的数量有所增加,接受血液透析(HD)、腹膜透析(PD)和肾移植(RT)的糖尿病患者的死亡率一直高于非糖尿病患者。本研究试图根据肾脏替代治疗(RRT)方式,对三组患者的临床特征、累积生存率和技术生存率进行回顾性比较,并分析与死亡率相关的危险因素。本研究纳入了1986年至1995年间在Severance医院确诊为糖尿病ESRD且开始透析或接受肾移植的229例患者,并对其病历进行了回顾。高血压是所有研究组中最常见的合并症。心血管疾病的患病率是三组之间唯一有显著差异的合并症,在PD组中最高(24.4%),在RT组中最低(8%)。在未对年龄和性别进行调整的患者累积生存率分析中,RT组的生存率最高,HD组和PD组的累积生存率相似。接受HD、PD和RT治疗的患者5年生存率分别为28.8%、19.8%和72.0%。即使对年龄进行调整,HD组和PD组患者的累积生存率也未观察到差异。当对年龄、性别和危险因素进行调整时,60岁以下男性患者中RT组的相对死亡率显著较低。除60岁以下男性患者外,PD组的相对死亡率略低,尽管差异不显著。患者生存的多因素Cox回归分析显示,年龄、血清白蛋白、尿素氮、平均住院天数、RRT开始时是否存在心血管疾病与死亡率相关。技术生存率分析显示,HD组的结果优于PD组,但由于能够研究动静脉内瘘功能存在局限性,干扰了技术生存率分析的准确性。总之,PD组和HD组患者的生存率无差异,RT组的生存率最佳。因此,如果没有其他肾移植禁忌证,应积极考虑对糖尿病ESRD患者进行肾移植。